HPV testing and Pap test: Role for a combined approach in a non-screened population

International Journal of Biological Markers

Volumn 21, Issue 3, 2006, Pages 149-156

  Marchetti, Ivo ^a   Zavaglia, K ^a   Bertacca, G ^a   Aretini, P ^b   Matteoli, B ^a   Viacava, P ^a   Prato, B ^a   De Punzio, C ^a   Genazzani, A R ^a   Bevilacqua, G ^a   Di Coscio, G ^a  

^a UNIVERSITY OF PISA   (Italy)

^b MGM   (Italy)

Author keywords

HPV infection; HSIL; LSIL; Pap test

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOLOGY; DOT HYBRIDIZATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; SCREENING TEST; SQUAMOUS EPITHELIUM; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM; VERRUCA VULGARIS; VIRUS IDENTIFICATION; VIRUS TYPING; WART VIRUS;

HUMAN PAPILLOMAVIRUS;

EID: 33750496254     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.4997     Document Type: Article

References (32)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-6.
2. Rosso S, Spitale A, Balzi D, Franceschi S, Zanetti R. [Estimate of cancer incidence in Italian regions, 2001]. Epidemiol Prev 2004; 28: 247-57.
3. Giard RW. False-negative rate of cervical cytology: sense and sensitivity. Diagn Cytopathol 2001; 25: 275-7.
4. McLachlin CM. Human papillomavirus in cervical neoplasia. Role, risk factors, and implications. Clin Lab Med 2000; 20: 257-70, v.
5. de Villiers E. Taxonomic classification of papillomaviruses. Papillomavirus Rep 2001; 12: 57-63.
6. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-9.
7. Cuzick J, Sasieni P, Davies P, et al. A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions. Br J Cancer 2000; 83: 561-5.
8. Olsen AO, Gjoen K, Sauer T, et al. Human papillomavirus and cervical intraepithelial neoplasia grade II-III: a population-based case-control study. Int J Cancer 1995; 61: 312-5.
9. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27.
10. Castle PE, Wacholder S, Sherman ME, et al. Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women. Cancer 2002; 95: 2145-51.
11. Isacson C, Sherman, ME. Human papillomavirus. In: Ducatman BS, Wang, HE, eds. The pap smear: Controversies in practice. New York: Oxford University Press, 2002; 99.
12. Solomon D, Nayar R, eds. The Bethesda System for reporting cervical cytology. Definitions, criteria, and explanatory notes. New York: Springer-Verlag, 2004.
13. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287: 2114-9.
14. Wideroff L, Schiffman M, Haderer P, et al. Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions. J Infect Dis 1999; 180: 1424-8.
15. Noda K, Yajima A, Higashiiwai H, Sato A, Teshima K. Histopathologic criterion of dysplasia of the uterine cervix and its biological nature. Acta Cytol 1976; 20: 224-8.
16. Ueda Y, Enomoto T, Miyatake T, et al. Monoclonal expansion with integration of high-risk type human papillomaviruses is an initial step for cervical carcinogenesis: association of clonal status and human papillomavirus infection with clinical outcome in cervical intraepithelial neoplasia. Lab Invest 2003; 83: 1517-27.
17. Vizcaino AP, Moreno V, Bosch FX, et al. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer 2000; 86: 429-35.
18. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996; 46: 5-27.
19. Renshaw AA. Measuring sensitivity in gynecologic cytology: a review. Cancer 2002; 96: 210-7.
20. Cervical cancer. NIH Consensus Statement 1996; 14: 1-38.
21. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-65.
22. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102: 3-8.
23. Ducatman BS, Wang HH, eds. The Pap smear: Controversies in practice. New York: Oxford University Press, 2002.
24. Liaw KL, Glass AG, Manos MM, et al. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst 1999; 91: 954-60.
25. Smith JH. Bethesda 2001. Cytopathology 2002; 13: 4-10.
26. Jacobs MV, Walboomers JM, Snijders PJ, et al. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 2000; 87: 221-7.
27. Schlecht NF, Kulaga S, Robitaille J, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001; 286: 3106-14.
28. Castellsague X, Bosch FX, Munoz N. Environmental co-factors in HPV carcinogenesis. Virus Res 2002; 89: 191-9.
29. Clavel C, Masure M, Bory JP, et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 2001; 84: 1616-23.
30. Carozzi F, Ronco G, Confortini M, et al. Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing. Br J Cancer 2000; 83: 1462-7.
31. Iatrakis G, Kourounis G, Georgopoulos N, Karachotzitis J. Treatment delay and pathology results in women with low-grade squamous intraepithelial lesions. A preliminary study. Eur J Gynaecol Oncol 2004; 25: 376-8.
32. Kulasingam SL, Hughes JP, Kiviat NB, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 2002; 288: 1749-57.